Biohaven - Stock Price History | BHVN

Historical daily share price chart and data for Biohaven since 2022 adjusted for splits. The latest closing stock price for Biohaven as of November 29, 2022 is 15.40.
  • The all-time high Biohaven stock closing price was 152.20 on September 27, 2022.
  • The Biohaven 52-week high stock price is 152.56, which is 890.6% above the current share price.
  • The Biohaven 52-week low stock price is 9.45, which is 38.6% below the current share price.
  • The average Biohaven stock price for the last 52 weeks is 116.20.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Biohaven Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 103.8729 81.9100 148.4800 64.0700 137.8100 60.79%
2020 62.4714 53.3800 98.2400 27.5100 85.7100 57.44%
2019 47.8562 36.6900 67.0100 34.5200 54.4400 47.21%
2018 33.6381 28.0900 43.0000 22.4900 36.9800 37.06%
2017 27.4828 17.5000 38.2100 17.5000 26.9800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.982B $0.463B
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $168.264B 10.27
GSK (GSK) United Kingdom $68.657B 8.61
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.145B 19.02
Ginkgo Bioworks Holdings (DNA) United States $3.570B 0.00
Myovant Sciences (MYOV) United Kingdom $2.594B 0.00
Arcus Biosciences (RCUS) United States $2.073B 31.12
Emergent Biosolutions (EBS) United States $0.579B 4.55
Zymeworks (ZYME) Canada $0.493B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.261B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
SQZ Biotechnologies (SQZ) United States $0.078B 0.00
Gelesis Holdings (GLS) United States $0.028B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00